WENA

Investor Moves

Investor	Portfolio Value	Portfolio Change	Position Change	Avg Buy Price	Current Price
Ken GriffinCitadel Advisors $-27.3K ExitQ3 2024 $27k -- --

Trade WENA

About Anew Medical, Inc.

Anew Medical, Inc. is a biopharmaceutical firm dedicated to developing innovative treatments for conditions affecting the brain and nervous system, age-related illnesses, and specialized diagnostic tools. Their pipeline includes advanced cell and gene therapies specifically designed to alleviate symptoms of aging-related conditions, such as dementia, Alzheimer's disease, and various neuromuscular disorders. Additionally, Anew Medical is engaged in developing biologics and biosimilars for cancer treatment, alongside research into therapies targeting melanocortin receptors. A key strategic alliance exists with Japan's Okinawa Research Center, focusing on the collaborative research and development of Klotho gene therapy. This initiative aims to extend human longevity and diminish the impact of age-related diseases. The company maintains its headquarters in Omaha, Nebraska.

CEO: Joseph Sinkule

Market Data

Open: $0.78
High: $0.78
Low: $0.725
Volume: 20.6K
52W High: $5.11
52W Low: $0.70

Valuation

Market Cap: $15M
Enterprise Value: $17M

Financials

Free Cash Flow: $-1.3M
Revenue: $0
Net Income: $1.3M
Cash: $173k
Debt: $1.6M